Winterfeld, U. Et Al. 2015. PREGNANCY OUTCOME FOLLOWING MATERNAL EXPOSURE TO PREGABALIN: A REASON FOR CONCERN? A COLLABORATIVE ENTIS AND MOTHERISK STUDY. 12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics , (Madrid, Spain).

Winterfeld, U., Merlob, P., Baud, D., Rousson, V., Panchaud, A., Rothuizen, L. E., ... Bernard, N.(2015). PREGNANCY OUTCOME FOLLOWING MATERNAL EXPOSURE TO PREGABALIN: A REASON FOR CONCERN? A COLLABORATIVE ENTIS AND MOTHERISK STUDY . 12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics, Madrid, Spain

Winterfeld, U. Et Al. "PREGNANCY OUTCOME FOLLOWING MATERNAL EXPOSURE TO PREGABALIN: A REASON FOR CONCERN? A COLLABORATIVE ENTIS AND MOTHERISK STUDY," 12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics, Madrid, Spain, 2015

Winterfeld, U. Et Al. "PREGNANCY OUTCOME FOLLOWING MATERNAL EXPOSURE TO PREGABALIN: A REASON FOR CONCERN? A COLLABORATIVE ENTIS AND MOTHERISK STUDY." 12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics , Madrid, Spain, 2015

Winterfeld, U. Et Al. (2015) . "PREGNANCY OUTCOME FOLLOWING MATERNAL EXPOSURE TO PREGABALIN: A REASON FOR CONCERN? A COLLABORATIVE ENTIS AND MOTHERISK STUDY." 12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics , Madrid, Spain.

@conferencepaper{conferencepaper, author={U. Winterfeld Et Al. }, title={PREGNANCY OUTCOME FOLLOWING MATERNAL EXPOSURE TO PREGABALIN: A REASON FOR CONCERN? A COLLABORATIVE ENTIS AND MOTHERISK STUDY}, congress name={12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics}, city={Madrid}, country={Spain}, year={2015}}